$0.87 (9.41%)

Volume: 159.597k

Closed: Dec 02, 2022

Hollow Logo Score: -2.471

Cyclacel Pharmaceuticals Stock Forecast

$0.87 (9.41%)

Volume: 159.597k

Closed: Dec 02, 2022

Score Hollow Logo -2.471

Cyclacel Pharmaceuticals Stock Price (Quote) NASDAQ:CYCC

$0.87 ( 9.41% ) Friday, 2nd Dec 2022

Range Low Price High Price Comment
30 days $0.770 $1.44 Friday, 2nd Dec 2022 CYCC stock ended at $0.87. This is 9.41% more than the trading day before Thursday, 1st Dec 2022. During the day the stock fluctuated 14.29% from a day low at $0.770 to a day high of $0.88.
90 days $0.770 $1.75
52 weeks $0.770 $4.53

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
2022-12-02 $0.770 $0.88 $0.770 $0.87 159 597
2022-12-01 $0.81 $0.84 $0.790 $0.795 124 600
2022-11-30 $0.84 $0.84 $0.792 $0.80 104 947
2022-11-29 $0.89 $0.89 $0.790 $0.82 126 204
2022-11-28 $0.83 $0.89 $0.81 $0.82 231 066
2022-11-25 $0.89 $0.93 $0.81 $0.84 95 349
2022-11-23 $0.82 $0.93 $0.82 $0.88 67 851
2022-11-22 $0.91 $0.91 $0.81 $0.82 124 703
2022-11-21 $0.92 $0.96 $0.89 $0.90 272 750
2022-11-18 $1.10 $1.10 $1.00 $1.01 61 657
2022-11-17 $1.04 $1.09 $1.00 $1.05 199 194
2022-11-16 $1.11 $1.13 $1.06 $1.07 88 861
2022-11-15 $1.21 $1.23 $1.10 $1.10 137 327
2022-11-14 $1.10 $1.18 $1.10 $1.17 140 353
2022-11-11 $1.20 $1.24 $1.17 $1.18 34 267
2022-11-10 $1.14 $1.20 $1.14 $1.17 67 149
2022-11-09 $1.24 $1.26 $1.15 $1.16 75 549
2022-11-08 $1.24 $1.24 $1.20 $1.22 39 131
2022-11-07 $1.19 $1.26 $1.14 $1.26 135 571
2022-11-04 $1.22 $1.44 $1.11 $1.14 190 850
2022-11-03 $1.19 $1.24 $1.14 $1.14 82 379
2022-11-02 $1.27 $1.27 $1.19 $1.20 184 495
2022-11-01 $1.39 $1.40 $1.26 $1.26 119 935
2022-10-31 $1.44 $1.45 $1.38 $1.39 71 856
2022-10-28 $1.41 $1.48 $1.39 $1.42 93 204
2022-10-27 $1.45 $1.45 $1.40 $1.43 53 093
2022-10-26 $1.37 $1.46 $1.31 $1.45 250 683
2022-10-25 $1.31 $1.35 $1.26 $1.33 126 194
2022-10-24 $1.26 $1.30 $1.22 $1.28 105 658
2022-10-21 $1.22 $1.23 $1.18 $1.20 88 611
2022-10-20 $1.20 $1.26 $1.18 $1.20 56 835
2022-10-19 $1.28 $1.29 $1.20 $1.20 82 531
2022-10-18 $1.27 $1.31 $1.24 $1.28 81 705
2022-10-17 $1.27 $1.30 $1.25 $1.27 46 768
2022-10-14 $1.26 $1.34 $1.25 $1.30 41 298
2022-10-13 $1.20 $1.28 $1.20 $1.25 50 670
2022-10-12 $1.25 $1.25 $1.20 $1.21 28 855
2022-10-11 $1.24 $1.31 $1.21 $1.22 56 383
2022-10-10 $1.31 $1.31 $1.22 $1.26 81 671
2022-10-07 $1.35 $1.36 $1.27 $1.28 105 574
2022-10-06 $1.38 $1.39 $1.31 $1.37 21 993
2022-10-05 $1.33 $1.38 $1.30 $1.36 113 616
2022-10-04 $1.37 $1.41 $1.33 $1.39 89 792
2022-10-03 $1.49 $1.49 $1.32 $1.38 95 199
2022-09-30 $1.32 $1.51 $1.30 $1.46 233 981
2022-09-29 $1.34 $1.37 $1.31 $1.32 36 126
2022-09-28 $1.24 $1.41 $1.24 $1.37 105 938
2022-09-27 $1.27 $1.32 $1.23 $1.26 51 391
2022-09-26 $1.20 $1.31 $1.20 $1.24 99 611
2022-09-23 $1.30 $1.30 $1.20 $1.23 191 173

Hot Stocks To Watch:

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT